Filing Flows › Health Catalyst (HCAT) › Guidance history
Health Catalyst (HCAT) guidance history: what it guided and what it reported
Health Catalyst gave guidance in 3 earnings releases on file since May 11, 2026. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.8% against the guided midpoint.
Revenue
Met or beat 2 of 2 periods (2 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q3 2026 | $55.0M–$56.0M (Aug 6, 2026) | $56.3M | above the range | +1.4% |
| Q2 2026 | $68.0M–$70.0M (May 11, 2026) | $70.5M | above the range | +2.2% |
| FY2026 | $260M–$265M (May 11, 2026) → lowered $246M–$249M (Aug 6, 2026) → reaffirmed $246M–$249M (Nov 5, 2026) | — | to be reported | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q3 2026 | $0–$500K (Aug 6, 2026) | — | — | — |
| FY2026 | $30.0M–$33.0M (May 11, 2026) → lowered $18.0M–$18.5M (Aug 6, 2026) → reaffirmed $18.0M–$18.5M (Nov 5, 2026) | — | to be reported | — |
| Q2 2026 | $9.0M–$10.0M (May 11, 2026) | — | — | — |
The latest quarter
Health Catalyst, Q3 2026: revenue $56.3M (-26% year over year), operating margin 89.1%, net earnings $40.5M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
Questions
Does Health Catalyst beat its guidance?
Health Catalyst gave guidance in 3 earnings releases on file since May 11, 2026. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.8% against the guided midpoint.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.